Brown, John V <br/><br/>
A pilot study evaluating a novel regimen comprised of carboplatin, paclitaxel, and bevacizumab for advanced-stage ovarian carcinoma.  [electronic resource] 

 -  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society  Oct 2010 
 - 1132-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-1438 
<br/><br/><label>Standard No.: </label>10.1111/igc.0b013e3181e94331  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab<br/>Carboplatin--administration & dosage<br/>Carcinoma, Papillary--drug therapy<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Fallopian Tube Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Peritoneal Neoplasms--drug therapy<br/>Pilot Projects<br/>Survival Rate<br/>Treatment Outcome